"Our revenues are higher than Tweed’s,” says Wayne. “And our patient numbers are certainly higher than Organigram’s – they don’t have supply right now and might not for some time. We’re making a profit. We’re doing what companies are supposed to do."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.